Uptake of pneumococcal vaccination in older people in northern Israel
The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal...
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Elsevier
2021-12-01
|
| Sarja: | Preventive Medicine Reports |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2211335521002436 |